Papautsky EL, Carlson M, Johnson SM, Montague H, et al. Characterizing experiences of non-medical switching to trastuzumab biosimilars using data from internet-based surveys with US-based oncologists and breast cancer patients. Breast Cancer Res Treat 2022 May 14. pii: 10.1007/s10549-022-06615.
PMID: 35568748